Market Research Logo

Plasma Fractionation Market by Product (IVIG, Albumin, Factor VIII, von Willebrand Factor, PCC, Protease Inhibitor), Application (Immunology, Hematology, Critical Care, Rheumatology), End User (Hospital, Clinic, Academic Institute) - Global Forecast to 20

Plasma Fractionation Market by Product (IVIG, Albumin, Factor VIII, von Willebrand Factor, PCC, Protease Inhibitor), Application (Immunology, Hematology, Critical Care, Rheumatology), End User (Hospital, Clinic, Academic Institute) - Global Forecast to 2023

The plasma fractionation market is projected to reach to USD 29.50 billion by 2023 from an estimated USD 21.23 billion in 2018. The growing geriatric population across the globe, increasing use of immunoglobulins in various therapeutic areas, growing prevalence of respiratory diseases and uptake of alpha-1-antitrypsin, and increase in plasma collection are the factors driving this market. However, the emergence of recombinant alternatives, high cost of plasma products, and limited reimbursement may hinder the growth of this market.

The protease inhibitors segment is expected to grow at the highest CAGR during the forecast period
On the basis of product, the plasma fractionation market is segmented into immunoglobulins, coagulation factor concentrates, albumin, protease inhibitors, and other plasma products. The protease inhibitors segment is expected to witness the highest growth during the forecast period. The high growth of this segment is primarily attributed to the increasing prevalence of alpha-1 antitrypsin deficiency and increasing number of various respiratory diseases.

The pulmonology segment is projected to witness the highest growth during the forecast period
Based on the application, the plasma fractionation market is classified into neurology, immunology, hematology, critical care, pulmonology, hemato-oncology, rheumatology, and other applications. The pulmonology segment
is expected to grow at the highest CAGR during the forecast period. This can largely be attributed to the increasing use of immunoglobulins and protease inhibitors in the treatment of various respiratory diseases such as AATD and COPD, asthma, and respiratory tract infections.

The hospitals and clinics segment is expected to grow at the highest CAGR during the forecast period
On the basis of type of end user, the market is segmented into hospitals & clinics, clinical research laboratories, and academic institutes. During the forecast period, the hospitals & clinics segment is expected to grow at the highest CAGR. The high growth of this segment can be attributed to the increasing adoption of plasma products in the treatment of various immunological, neurological, and bleeding disorders; large patient pool treated in hospitals; growing number of hospitals & clinics across the globe; and increasing number of collaborations between the manufacturers of plasma products and hospitals.

Asia Pacific to witness the highest growth during the forecast period
Asia Pacific is expected to witness the highest growth during the forecast period (2018 to 2023). The region’s large geriatric population, large population, improving healthcare infrastructure, increasing incidences of immunological and bleeding diseases, increasing focus diagnosis and prophylactic treatment, and increasing awareness about technologically advanced products are driving the growth of this market.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–46%, Tier 2–33% and Tier 3–21%
• By Designation – C Level–43%, Director Level–35%, Others–22%
• By Region – North America–34%, Europe–26%, Asia Pacific–24%, Latin America–12%, Middle East and Africa- 4%

Some of the major market players in the plasma fractionation market are CSL (Australia), Grifols (Spain), Shire (Ireland), Octapharma (Switzerland), Kedrion (Italy), Bio Product Laboratory (UK), Sanquin (Netherlands), LFB (France), Biotest (Germany), Japan Blood Products Organization, China Biologic Products (China), Green Cross Corporation (South Korea), and Shanghai RAAS Blood Products (China).

Research Coverage:
The report analyzes the plasma fractionation market and aims at estimating the market size and future growth potential of this market based on various segments such as product, application, end user, and region. The report also includes a volume data analysis for various plasma products across the globe and a competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a greater share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global plasma fractionation market. The report analyzes the global plasma fractionation market by product, application, end user, and region.
• Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global plasma fractionation market.
• Market Development: Comprehensive information on the lucrative emerging markets by product, application, end user, and region.
• Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the global plasma fractionation market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of leading players in the global plasma fractionation market.


1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Scope Of The Study
1.3.1 Markets Covered
1.3.2 Years Considered For The Study
1.4 Currency
1.5 Stakeholders
2 Research Methodology
2.1 Research Approach
2.1.1 Secondary Sources
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Sources
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.2.1 Bottom-up Approach
2.2.2 Top-down Approach
2.3 Market Breakdown And Data Triangulation
2.4 Market Share Estimation
2.5 Assumptions For The Study
2.6 Limitations
3 Executive Summary
4 Premium Insights
4.1 Plasma Fractionation Market Overview
4.2 Asia Pacific: Plasma Fractionation Market, By Product, 2018
4.3 Geographical Snapshot Of The Plasma Fractionation Market
4.4 Plasma Fractionation Market: Regional Mix
4.5 Plasma Fractionation Market, Developing Countries Vs.
Developed Countries
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Growing Use Of Immunoglobulins In Various Therapeutic Areas
5.2.1.2 Rising Geriatric Population Across The Globe
5.2.1.3 Growing Prevalence Of Respiratory Diseases And Aatd Driving The Uptake Of Alpha-1-antitrypsin
5.2.1.4 Increase In Plasma Collection
5.2.2 Market Restraints
5.2.2.1 High Cost And Limited Reimbursement
5.2.2.2 Emergence Of Recombinant Alternatives
5.2.3 Market Opportunity
5.2.3.1 Increasing Number Of Hemophilia Patients
5.2.4 Market Challenge
5.2.4.1 Stringent Government Regulations
6 Industry Insights
6.1 Introduction
6.2 Key Industry Trends
6.2.1 Focus On Increasing Fractionation Capacities And Geographical Expansions
6.2.2 New Indications For Plasma Products
6.2.3 Rising Adoption Of Scig
6.2.4 Increasing Number Of Fractionator-owned Plasma Collection Centers
6.2.5 Growing Plasma Products Market In China
6.2.6 Increasing Focus Of Plasma Fractionators Towards Manufacturing And Developing Recombinant Factors
6.3 Porter’s Five Forces
6.3.1 Threat From New Entrants
6.3.2 Threat Of Substitutes
6.3.3 Bargaining Power Of Suppliers
6.3.4 Bargaining Power Of Buyers
6.3.5 Intensity Of Competitive Rivalry
6.4 Vendor Benchmarking
7 Plasma Fractionation Market, By Product
7.1 Introduction
7.2 Immunoglobulin
7.2.1 Intravenous Immunoglobulin (Ivig)
7.2.2 Subcutaneous Immunoglobulin (Scig)
7.2.3 Other Immunoglobulins
7.3 Coagulation Factor Concentrates
7.3.1 Factor Viii
7.3.2 Factor Ix
7.3.3 Von Willebrand Factor
7.3.4 Prothrombin Complex Concentrate
7.3.5 Fibrinogen Concentrates
7.3.6 Factor Xiii
7.4 Albumin
7.5 Protease Inhibitors
7.6 Other Plasma Products
8 Plasma Fractionation Market, By Application
8.1 Introduction
8.2 Neurology
8.3 Immunology
8.4 Hematology
8.5 Critical Care
8.6 Pulmonology
8.7 Hemato-oncology
8.8 Rheumatology
8.9 Other Applications
9 Plasma Fractionation Market, By End User
9.1 Introduction
9.2 Hospitals & Clinics
9.3 Clinical Research Laboratories
9.4 Academic Institutes
10 Geographic Analysis
10.1 Introduction
10.2 North America
10.2.1 Us
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 Italy
10.3.4 Spain
10.3.5 Uk
10.3.6 Rest Of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Malaysia
10.4.5 Rest Of Asia Pacific
10.5 Latin America
10.6 Middle East & Africa
11 Competitive Landscape
11.1 Overview
11.2 Market Share Analysis
11.3 Competitive Scenario And Trends
11.3.1 Expansions
11.3.2 Product Launches
11.3.3 Acquisitions
11.3.4 Agreements, Collaborations, Joint Ventures, And Partnerships
12 Company Profiles
(Overview, Strength Of Product Portfolio, Business Strategy Excellence, Products Offering, And Recent Developments)*
12.1 Csl
12.2 Grifols
12.3 Shire
12.4 Octapharma
12.5 Kedrion
12.6 Lfb
12.7 Biotest
12.8 Sanquin
12.9 China Biologic Products
12.10 Bio Products Laboratory (Bpl)
12.11 Japan Blood Products Organization
12.12 Green Cross Corporation
12.13 Shanghai Raas Blood Products
*Details On Overview, Strength Of Product Portfolio, Business Strategy Excellence, Products Offering, And Recent Developments Might Not Be Captured In Case Of Unlisted Companies.
13 Appendix
13.1 Insights Of Industry Experts
13.2 Discussion Guide
13.3 Available Customization
13.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.5 Introducing Rt: Real-time Market Intelligence
13.6 Related Report
13.7 Author Details
List Of Tables
Table 1 Plasma Fractionation Market: Impact Analysis
Table 2 On-label And Off-label Indications Of Ivig
Table 3 Number Of Clinical Studies On Immunoglobulins, By Region, 2017
Table 4 Increase In Geriatric Population From 2000 To 2050 Across The Globe
Table 5 Number Of Plasma Collection Centers (2017)
Table 6 Number Of Hemophilia Patients In Developed And Emerging
Countries, 2016
Table 7 Characteristics Of Plasma For Fractionation
Table 8 Fractionation Capacity Expansions By Major Player
Table 9 Per Capita Consumption Of Ivig And Albumin, By Country (2014)
Table 10 China:top Players In Albumin Market, 2017
Table 11 Major Local Players In China
Table 12 Regional Impact Analysis Of Recombinant Factors On Plasma-derived Products
Table 13 Product Portfolio Analysis: Plasma Fractionation Market
Table 14 Plasma Fractionation Market, By Product, 2016–2023 (Usd Million)
Table 15 Immunoglobulin Market, By Type, 2016–2023 (Usd Million)
Table 16 Immunoglobulin Market, By Country, 2016–2023 (Usd Million)
Table 17 Global Immunoglobulin Market, By Region, 2016–2023 (Metric Tons)
Table 18 Intravenous Immunoglobulin Offered By Key Market Players
Table 19 Ivig Market, By Country, 2016–2023 (Usd Million)
Table 20 Ivig Market Share Analysis, By Key Player, 2017
Table 21 Comparison Of Pros And Cons, Ivig Vs Scig Therapy
Table 22 Scig Offered By Key Market Players
Table 23 Scig Market, By Country, 2016–2023 (Usd Million)
Table 24 Other Immunoglobulins Offered By Key Market Players
Table 25 Other Immunoglobulins Market, By Country, 2016–2023 (Usd Million)
Table 26 Coagulation Factor Concentrates Market, By Type,
2016–2023 (Usd Million)
Table 27 Coagulation Factor Concentrates Market, By Country,
2016–2023 (Usd Million)
Table 28 Factor Viii Offered By Key Market Players
Table 29 Global Factor Viii Market, By Region,
2016–2023 (Million International Units)
Table 30 Factor Viii Market, By Country, 2016–2023 (Usd Million)
Table 31 Factor Viii Market Share Analysis, By Key Player, 2017
Table 32 Factor Ix Offered By Key Market Players
Table 33 Factor Ix Market, By Country, 2016–2023 (Usd Million)
Table 34 Von Willebrand Factor Offered By Key Market Players
Table 35 Von Willebrand Factor Market, By Country, 2016–2023 (Usd Million)
Table 36 Prothrombin Complex Concentrate Offered By Key Market Players
Table 37 Prothrombin Complex Concentrate Market, By Country,
2016–2023 (Usd Million)
Table 38 Fibrinogen Concentrates Offered By Key Market Players
Table 39 Fibrinogen Concentrates Market, By Country, 2016–2023 (Usd Million)
Table 40 Factor Xiii Offered By Key Market Players
Table 41 Factor Xiii Market, By Country, 2016–2023 (Usd Million)
Table 42 Albumin Offered By Key Market Players
Table 43 Albumin Market, By Country, 2016–2023 (Usd Million)
Table 44 Global Albumin Market, By Region, 2016–2023 (Metric Tons)
Table 45 Protease Inhibitors Offered By Key Market Players
Table 46 Protease Inhibitors Market, By Country, 2016–2023 (Usd Million)
Table 47 Other Plasma Products Market, By Country, 2016–2023 (Usd Million)
Table 48 Plasma Fractionation Market, By Application, 2016–2023 (Usd Million)
Table 49 Number Of Dalys For Neurological Disorders And A Percentage Of Dalys Projected For 2005, 2015, And 2030
Table 50 Plasma-derived Products And Its Applications In Neurology
Table 51 Plasma Fractionation Market For Neurology, By Country,
2016–2023 (Usd Million)
Table 52 List Of Fda Approved Indications For Immunoglobulins In Immunology
Table 53 Prevalence Of Pid, By Region, 2013 Vs. 2015
Table 54 Plasma-derived Products And Its Applications In Immunology
Table 55 Plasma Fractionation Market For Immunology, By Country,
2016–2023 (Usd Million)
Table 56 Number Of Hemophilic Patients (2012–2016)
Table 57 Plasma-derived Products And Its Applications In Hematology
Table 58 Plasma Fractionation Market For Hematology, By Country,
2016–2023 (Usd Million)
Table 59 Plasma-derived Products And Its Applications In Critical Care
Table 60 Plasma Fractionation Market For Critical Care, By Country,
2016–2023 (Usd Million)
Table 61 Plasma-derived Products And Its Applications In Pulmonology
Table 62 Plasma Fractionation Market For Pulmonology, By Country,
2016–2023 (Usd Million)
Table 63 Estimated Cancer Incidence, By Region, 2012 Vs. 2015
Table 64 Plasma-derived Products And Its Applications In Hemato-oncology
Table 65 Plasma Fractionation Market For Hemato-oncology, By Country,
2016–2023 (Usd Million)
Table 66 Plasma Fractionation Market For Rheumatology, By Country,
2016–2023 (Usd Million)
Table 67 Plasma-derived Products And Its Other Applications
Table 68 Plasma Fractionation Market For Other Applications, By Country, 2016–2023 (Usd Million)
Table 69 Plasma Fractionation Market, By End User, 2016–2023 (Usd Million)
Table 70 Plasma Fractionation Market For Hospitals & Clinics, By Country, 2016–2023 (Usd Million)
Table 71 Clinical Studies On Albumin & Immunoglobulin (2017)
Table 72 Plasma Fractionation Market For Clinical Research Laboratories,
By Country, 2016–2023 (Usd Million)
Table 73 Plasma Fractionation Market For Academic Institutes, By Country, 2016–2023 (Usd Million)
Table 74 Number Of Plasma Fractionation Plants, By Region, 2014
Table 75 Plasma Fractionation Market, By Region, 2016–2023 (Usd Million)
Table 76 North America: Hemophilia Patients, 2013 Vs. 2016
Table 77 North America: Plasma Fractionation Market, By Country,
2016–2023 (Usd Million)
Table 78 North America: Plasma Fractionation Market, By Product,
2016–2023 (Usd Million)
Table 79 North America: Immunoglobulins Market, By Type,
2016–2023 (Usd Million)
Table 80 North America: Coagulation Factor Concentrates Market, By Type, 2016–2023 (Usd Million)
Table 81 North America: Plasma Fractionation Market, By Application,
2016–2023 (Usd Million)
Table 82 North America: Plasma Fractionation Market, By End User,
2016–2023 (Usd Million)
Table 83 Us: Number Of Plasma Donations & Plasma Donation Centers
Table 84 Us: Key Macroindicators
Table 85 Us: Plasma Fractionation Market, By Product, 2016–2023 (Usd Million)
Table 86 Us: Immunoglobulins Market, By Type, 2016–2023 (Usd Million)
Table 87 Us: Coagulation Factor Concentrates Market, By Type,
2016–2023 (Usd Million)
Table 88 Us: Plasma Fractionation Market, By Application,
2016–2023 (Usd Million)
Table 89 Us: Plasma Fractionation Market, By End User, 2016–2023 (Usd Million)
Table 90 Canada: Key Macroindicators
Table 91 Canada: Plasma Fractionation Market, By Product,
2016–2023 (Usd Million)
Table 92 Canada: Immunoglobulins Market, By Type, 2016–2023 (Usd Million)
Table 93 Canada: Coagulation Factor Concentrates Market, By Type,
2016–2023 (Usd Million)
Table 94 Canada: Plasma Fractionation Market, By Application,
2016–2023 (Usd Million)
Table 95 Canada: Plasma Fractionation Market, By End User,
2016–2023 (Usd Million)
Table 96 Europe: Number Of Plasma Donation Centers
Table 97 Plasma Fractionation Plants In Europe (2017)
Table 98 Europe: Plasma Fractionation Market, By Country,
2016–2023 (Usd Million)
Table 99 Europe: Plasma Fractionation Market, By Product,
2016–2023 (Usd Million)
Table 100 Europe: Immunoglobulins Market, By Type, 2016–2023 (Usd Million)
Table 101 Europe: Coagulation Factor Concentrates Market, By Type,
2016–2023 (Usd Million)
Table 102 Europe: Plasma Fractionation Market, By Application,
2016–2023 (Usd Million)
Table 103 Europe: Plasma Fractionation Market, By End User,
2016–2023 (Usd Million)
Table 104 Germany: Key Macroindicators
Table 105 Germany: Plasma Fractionation Market, By Product,
2016–2023 (Usd Million)
Table 106 Germany: Immunoglobulins Market, By Type, 2016–2023 (Usd Million)
Table 107 Germany: Coagulation Factor Concentrates Market, By Type,
2016–2023 (Usd Million)
Table 108 Germany: Plasma Fractionation Market, By Application,
2016–2023 (Usd Million)
Table 109 Germany: Plasma Fractionation Market, By End User,
2016–2023 (Usd Million)
Table 110 Number Of People With Bleeding Disorders In France: 2012–2016
Table 111 France: Key Macroindicators
Table 112 France: Plasma Fractionation Market, By Product,
2016–2023 (Usd Million)
Table 113 France: Immunoglobulins Market, By Type, 2016–2023 (Usd Million)
Table 114 France: Coagulation Factor Concentrates Market, By Type,
2016–2023 (Usd Million)
Table 115 France: Plasma Fractionation Market, By Application,
2016–2023 (Usd Million)
Table 116 France: Plasma Fractionation Market, By End User,
2016–2023 (Usd Million)
Table 117 Italy: Number Of Blood Donations, 2011 Vs. 2013
Table 118 Production Of Plasma Products In Italy (2013)
Table 119 Italy: Key Macroindicators
Table 120 Italy: Plasma Fractionation Market, By Product,
2016–2023 (Usd Million)
Table 121 Italy: Immunoglobulins Market, By Type, 2016–2023 (Usd Million)
Table 122 Italy: Coagulation Factor Concentrates Market, By Type,
2016–2023 (Usd Million)
Table 123 Italy: Plasma Fractionation Market, By Application,
2016–2023 (Usd Million)
Table 124 Italy: Plasma Fractionation Market, By End User,
2016–2023 (Usd Million)
Table 125 Spain: Key Macroindicators
Table 126 Spain: Plasma Fractionation Market, By Product,
2016–2023 (Usd Million)
Table 127 Spain: Immunoglobulins Market, By Type, 2016–2023 (Usd Million)
Table 128 Spain: Coagulation Factor Concentrates Market, By Type,
2016–2023 (Usd Million)
Table 129 Spain: Plasma Fractionation Market, By Application,
2016–2023 (Usd Million)
Table 130 Spain: Plasma Fractionation Market, By End User,
2016–2023 (Usd Million)
Table 131 Usage Of Immunoglobulins
Table 132 Estimated Number Of Hemophilia A And Hemophilia B Patients In The Uk, 2012–2016
Table 133 Uk: Key Macroindicators
Table 134 Uk: Plasma Fractionation Market, By Product, 2016–2023 (Usd Million)
Table 135 Uk: Immunoglobulins Market, By Type, 2016–2023 (Usd Million)
Table 136 Uk: Coagulation Factor Concentrates Market, By Type,
2016–2023 (Usd Million)
Table 137 Uk: Plasma Fractionation Market, By Application,
2016–2023 (Usd Million)
Table 138 Uk: Plasma Fractionation Market, By End User, 2016–2023 (Usd Million)
Table 139 Total Number Of Hemophilia Patients In The Roe: 2012–2016
Table 140 Roe: Plasma Fractionation Market, By Product, 2016–2023 (Usd Million)
Table 141 Roe: Immunoglobulins Market, By Type, 2016–2023 (Usd Million)
Table 142 Roe: Coagulation Factor Concentrates Market, By Type,
2016–2023 (Usd Million)
Table 143 Roe: Plasma Fractionation Market, By Application,
2016–2023 (Usd Million)
Table 144 Roe: Plasma Fractionation Market, By End User,
2016–2023 (Usd Million)
Table 145 Apac: Plasma Fractionation Market, By Country,
2016–2023 (Usd Million)
Table 146 Apac: Plasma Fractionation Market, By Product,
2016–2023 (Usd Million)
Table 147 Apac: Immunoglobulins Market, By Type, 2016–2023 (Usd Million)
Table 148 Apac: Coagulation Factor Concentrates Market, By Type,
2016–2023 (Usd Million)
Table 149 Apac: Plasma Fractionation Market, By Application,
2016–2023 (Usd Million)
Table 150 Apac: Plasma Fractionation Market, By End User,
2016–2023 (Usd Million)
Table 151 China: Key Macroindicators
Table 152 China: Plasma Fractionation Market, By Product,
2016–2023 (Usd Million)
Table 153 China: Immunoglobulins Market, By Type, 2016–2023 (Usd Million)
Table 154 China: Coagulation Factor Concentrates Market, By Type,
2016–2023 (Usd Million)
Table 155 China: Plasma Fractionation Market, By Application,
2016–2023 (Usd Million)
Table 156 China: Plasma Fractionation Market, By End User,
2016–2023 (Usd Million)
Table 157 Japan: Key Macroindicators
Table 158 Japan: Plasma Fractionation Market, By Product,
2016–2023 (Usd Million)
Table 159 Japan: Immunoglobulins Market, By Type, 2016–2023 (Usd Million)
Table 160 Japan: Coagulation Factor Concentrates Market, By Type,
2016–2023 (Usd Million)
Table 161 Japan: Plasma Fractionation Market, By Application,
2016–2023 (Usd Million)
Table 162 Japan: Plasma Fractionation Market, By End User,
2016–2023 (Usd Million)
Table 163 India: Number Of Patients With Bleeding Disorders: 2012–2016
Table 164 India: Key Macroindicators
Table 165 India: Plasma Fractionation Market, By Product,
2016–2023 (Usd Million)
Table 166 India: Immunoglobulins Market, By Type, 2016–2023 (Usd Million)
Table 167 India: Coagulation Factor Concentrates Market, By Type,
2016–2023 (Usd Million)
Table 168 India: Plasma Fractionation Market, By Application,
2016–2023 (Usd Million)
Table 169 India: Plasma Fractionation Market, By End User,
2016–2023 (Usd Million)
Table 170 Malaysia: Number Of Patients With Bleeding Disorders: 2012–2016
Table 171 Malaysia: Key Macroindicators
Table 172 Malaysia: Plasma Fractionation Market, By Product,
2016–2023 (Usd Million)
Table 173 Malaysia: Immunoglobulins Market, By Type, 2016–2023 (Usd Million)
Table 174 Malaysia: Coagulation Factor Concentrates Market, By Type,
2016–2023 (Usd Thousand)
Table 175 Malaysia: Plasma Fractionation Market, By Application,
2016–2023 (Usd Million)
Table 176 Malaysia: Plasma Fractionation Market, By End User,
2016–2023 (Usd Million)
Table 177 Roapac: Plasma Fractionation Market, By Product,
2016–2023 (Usd Million)
Table 178 Roapac: Immunoglobulins Market, By Type, 2016–2023 (Usd Million)
Table 179 Roapac: Coagulation Factor Concentrates Market, By Type,
2016–2023 (Usd Million)
Table 180 Roapac: Plasma Fractionation Market, By Application,
2016–2023 (Usd Million)
Table 181 Roapac: Plasma Fractionation Market, By End User,
2016–2023 (Usd Million)
Table 182 Latin America: Plasma Fractionation Market, By Product,
2016–2023 (Usd Million)
Table 183 Latin America: Immunoglobulins Market, By Type,
2016–2023 (Usd Million)
Table 184 Latin America: Coagulation Factor Concentrates Market, By Type, 2016–2023 (Usd Million)
Table 185 Latin America: Plasma Fractionation Market, By Application,
2016–2023 (Usd Million)
Table 186 Latin America: Plasma Fractionation Market, By End User,
2016–2023 (Usd Million)
Table 187 Hemophilia Patients In The Middle East And Africa: 2012–2016
Table 188 Per Capita Consumption Of Factor Ix And Viii (Iu/Total Population:
2012–2016)
Table 189 Middle East & Africa: Plasma Fractionation Market, By Product,
2016–2023 (Usd Million)
Table 190 Middle East & Africa: Immunoglobulins Market, By Type,
2016–2023 (Usd Million)
Table 191 Middle East & Africa: Coagulation Factor Concentrates Market,
By Type, 2016–2023 (Usd Million)
Table 192 Middle East & Africa: Plasma Fractionation Market, By Application, 2016–2023 (Usd Million)
Table 193 Middle East & Africa: Plasma Fractionation Market, By End User,
2016–2023 (Usd Million)
Table 194 Expansions, January 2014 To December 2017
Table 195 Product Launches, January 2014 To December 2017
Table 196 Acquisitions, January 2014 To December 2017
Table 197 Agreements, Collaborations, Joint Ventures, And Partnerships, January 2014 To December 2017
List Of Figures
Figure 1 Research Design
Figure 2 Breakdown Of Primary Interviews: By Company Type, Designation,
And Region
Figure 3 Data Triangulation Methodology
Figure 4 Immunoglobulins Segment To Dominate The Plasma Fractionation Market, By Product, During 2018 To 2023
Figure 5 Neurology Segment To Register The Highest Growth During The Forecast Period
Figure 6 Plasma Fractionation Market, By End User, 2018 Vs. 2023 (Usd Million)
Figure 7 Geographic Snapshot: Plasma Fractionation Market In 2017
Figure 8 Growing Use Of Immunoglobulins In Various Therapeutic Areas Is The Major Factor Driving Market Growth
Figure 9 Albumin Accounted For The Largest Market Share In 2017
Figure 10 The Us Accounted For The Largest Share Of The Plasma Fractionation Market In 2017
Figure 11 Asia Pacific To Register The Highest Cagr During The Forecast Period
Figure 12 Developing Countries To Register A Higher Growth Rate During The Forecast Period
Figure 13 Copd And Asthma Prevalence, By Country, 2015
Figure 14 Global Percentage Of Deaths From Respiratory Diseases, 2008 To 2030
Figure 15 Plasma Collection In Europe, 2005–2013
Figure 16 Source Plasma Collection In The Us, 2007–2016
Figure 17 Number Of Hemophilia A And Hemophilia B Patients Worldwide,
2012–2016
Figure 18 Increasing Consolidation And Rising Adoption Of Scig Are The Leading Industry Trends
Figure 19 Plasma Fractionation Market In China Vs. Developed Countries,
2018 Vs 2023
Figure 20 Porter’s Five Forces Analysis
Figure 21 Immunoglobulin Market Share Analysis, By Key Player, 2017
Figure 22 Estimated Lifetime Risk Of Alzheimer’s Disease, By Age & Sex (2016)
Figure 23 Prevalence Of Different Bleeding Disorders, By Country, 2016
Figure 24 Coagulation Factor Market Share Analysis, By Key Player, 2017
Figure 25 Mean Per Capita Usage Of Factor Viii (2016)
Figure 26 Mean Per Capita Usage Of Factor Ix (2016)
Figure 27 Albumin Market Share Analysis, By Key Player, 2017
Figure 28 Neurology Segment Will Continue To Dominate The Plasma Fractionation Market From 2018 To 2023
Figure 29 Number Of Hemophilia Patients In Major Countries, 2016
Figure 30 Hospitals & Clinics Segment To Register The Highest Cagr During The Forecast Period
Figure 31 Plasma Fractionation Market: Geographic Growth Opportunities
Figure 32 North America: Plasma Fractionation Market Snapshot
Figure 33 North America: Plasma Fractionation Market Share Analysis,
By Key Player, 2017
Figure 34 Plasma Collection Volume In The Us, 2007–2016
Figure 35 Plasma Collection Centers In The Us, 2005–2016
Figure 36 Us: Plasma Fractionation Market Share Analysis, By Key Player, 2017
Figure 37 Europe: Plasma Fractionation Market Snapshot
Figure 38 Europe: Plasma Fractionation Market Share Analysis,
By Key Player, 2017
Figure 39 Hemophilia A & B Patients In Germany, 2013–2016
Figure 40 Apac: Plasma Fractionation Market Snapshot
Figure 41 Key Strategies Adopted By Players (Jan 2014–december 2017)
Figure 42 Global Plasma Fractionation Market Share Analysis,
By Key Player, 2017
Figure 43 Csl: Company Snapshot (2017)
Figure 44 Grifols: Company Snapshot (2016)
Figure 45 Shire: Company Snapshot (2016)
Figure 46 Octapharma: Company Snapshot (2016)
Figure 47 Kedrion: Company Snapshot (2016)
Figure 48 Lfb: Company Snapshot (2016)
Figure 49 Biotest: Company Snapshot (2016)
Figure 50 Sanquin: Company Snapshot (2015)
Figure 51 China Biologic Products: Company Snapshot (2016)
Figure 52 Japan Blood Products Organization: Company Snapshot (2016)
Figure 53 Green Cross Corporation: Company Snapshot (2016)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report